Dr. Thomas Enzler
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Cancer
Studies Adenocarcinoma
6 reported clinical trials
10 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
BRCA1 positive
2Adenocarcinoma
Stage IV
PALB2 positive
BRCA1 positive
Affiliated Hospitals
Clinical Trials Thomas Enzler is currently running
Botensilimab + Chemotherapy
for Pancreatic Cancer
This trial is testing whether adding a new drug, botensilimab, to standard chemotherapy can better treat patients with advanced pancreatic cancer. The study will ensure the new drug is safe and determine the right dose. It will also compare the effectiveness of the new combination treatment to chemotherapy alone.
Recruiting1 award Phase 2
Pre- and Post-Surgery Chemotherapy
for Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller; therefore, may reduce the extent of surgery. Additionally, it may make it easier for the surgeon to distinguish between normal and cancerous tissue. Giving chemotherapy after surgery may kill any remaining tumor cells. This study will determine whether giving chemotherapy before surgery increases the length of time before the cancer may return and whether it will increase a patient's life span compared to the usual approach.
Recruiting1 award Phase 2 & 315 criteria
More about Thomas Enzler
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Thomas Enzler has experience with
- Nab-paclitaxel
- Cisplatin
- Gemcitabine Hydrochloride
- Cabozantinib
- Niraparib
- Olaparib
Breakdown of trials Thomas Enzler has run
Cancer
Gallbladder Cancer
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Enzler specialize in?
Thomas Enzler focuses on Cancer and Adenocarcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thomas Enzler currently recruiting for clinical trials?
Yes, Thomas Enzler is currently recruiting for 3 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Thomas Enzler has studied deeply?
Yes, Thomas Enzler has studied treatments such as Nab-paclitaxel, Cisplatin, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Thomas Enzler?
Apply for one of the trials that Thomas Enzler is conducting.
What is the office address of Thomas Enzler?
The office of Thomas Enzler is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.